![H. Shepard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Shepard
Gründer bei
Enosi Life Sciences Corp.
Profil
H.
Michael Shepard was the founder of Receptor BioLogix, Inc. (founded in 2003, titles: President & Chief Scientific Officer) and Enosi Life Sciences Corp.
(founded in 2018, titles: President, Director & Chief Scientific Officer).
Former jobs include Independent Director at Nevis Brands, Inc., Principal at Genentech, Inc. (1980-1992), Chief Scientific Officer & Vice President at Halozyme Therapeutics, Inc. (2012-2017), President & Chief Scientific Officer at NewBiotics, Inc. (1997-2008), and Chief Scientific Officer & Vice President-Research at Canji, Inc. (1992-1997).
Education includes a doctorate from Indiana University and an undergraduate degree from the University of California, Davis.
Aktive Positionen von H. Shepard
| Unternehmen | Position | Beginn |
|---|---|---|
Enosi Life Sciences Corp.
 Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Gründer | 16.08.2018 |
Ehemalige bekannte Positionen von H. Shepard
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
Receptor BioLogix, Inc.
 Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Gründer | 02.01.2008 |
NewBiotics, Inc.
 NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Präsident | 01.01.2008 |
Canji, Inc.
 Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Technik-/Wissenschafts-/F&E-Leiter | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von H. Shepard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Health Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevis Brands, Inc.
 Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Health Technology |
